| Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. RS Warren, H Yuan, MR Matli, NA Gillett, N Ferrara The Journal of clinical investigation 95 (4), 1789-1797, 1995 | 952 | 1995 |
| Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis K Kinkel, Y Lu, M Both, RS Warren, RF Thoeni Radiology 224 (3), 748-756, 2002 | 917 | 2002 |
| Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy ST Pullarkat, J Stoehlmacher, V Ghaderi, YP Xiong, SA Ingles, A Sherrod, ... The pharmacogenomics journal 1 (1), 65-70, 2001 | 740 | 2001 |
| Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains: association with endothelial cell … D Guo, Q Jia, HY Song, RS Warren, DB Donner Journal of Biological Chemistry 270 (12), 6729-6733, 1995 | 607 | 1995 |
| Microsatellite instability predicts improved response to adjuvant therapy with irinotecan, fluorouracil, and leucovorin in stage III colon cancer: Cancer and Leukemia Group B … MM Bertagnolli, D Niedzwiecki, CC Compton, HP Hahn, M Hall, B Damas, ... Journal of clinical Oncology 27 (11), 1814-1821, 2009 | 478 | 2009 |
| Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481) NE Kemeny, D Niedzwiecki, DR Hollis, HJ Lenz, RS Warren, ... Journal of Clinical Oncology 24 (9), 1395-1403, 2006 | 439 | 2006 |
| Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5′ nuclease quantitative reverse transcription-polymerase chain reaction TE Godfrey, SH Kim, M Chavira, DW Ruff, RS Warren, JW Gray, ... The Journal of molecular diagnostics 2 (2), 84-91, 2000 | 422 | 2000 |
| Mutations of the PATCHED Gene in Several Types of Sporadic Extracutaneous Tumors J Xie, RL Johnson, X Zhang, JW Bare, FM Waldman, PH Cogen, ... Cancer research 57 (12), 2369-2372, 1997 | 409 | 1997 |
| Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma RS Warren, H Yuan, MR Matli, N Ferrara, DB Donner Journal of Biological Chemistry 271 (46), 29483-29488, 1996 | 407 | 1996 |
| Tumor necrosis factor and the acute metabolic response to tissue injury in man. HF Starnes, RS Warren, M Jeevanandam, JL Gabrilove, W Larchian, ... The Journal of clinical investigation 82 (4), 1321-1325, 1988 | 406 | 1988 |
| Pancreatic adenocarcinoma MA Tempero, JP Arnoletti, S Behrman, E Ben-Josef, AB Benson, JD Berlin, ... Journal of the National Comprehensive Cancer Network 8 (9), 972-1017, 2010 | 392* | 2010 |
| β-Catenin regulates vascular endothelial growth factor expression in colon cancer V Easwaran, SH Lee, L Inge, L Guo, C Goldbeck, E Garrett, M Wiesmann, ... Cancer research 63 (12), 3145-3153, 2003 | 392 | 2003 |
| Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial S Mulvihill, R Warren, A Venook, A Adler, B Randlev, C Heise, D Kirn Gene therapy 8 (4), 308-315, 2001 | 375 | 2001 |
| Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis F Coll, J Phelan, GA Hill-Cawthorne, MB Nair, K Mallard, S Ali, ... Nature genetics 50 (2), 307-316, 2018 | 369 | 2018 |
| Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation LW Wu, LD Mayo, JD Dunbar, KM Kessler, MR Baerwald, EA Jaffe, ... Journal of Biological Chemistry 275 (7), 5096-5103, 2000 | 367 | 2000 |
| The relation between estrogen receptors and response rate to cytotoxic chemotherapy in metastatic breast cancer ME Lippman, JC Allegra, EB Thompson, R Simon, A Barlock, L Green, ... New England Journal of Medicine 298 (22), 1223-1228, 1978 | 344 | 1978 |
| Prognostic impact of deficient DNA mismatch repair in patients with stage III colon cancer from a randomized trial of FOLFOX-based adjuvant chemotherapy FA Sinicrope, MR Mahoney, TC Smyrk, SN Thibodeau, RS Warren, ... Journal of clinical oncology 31 (29), 3664-3672, 2013 | 329 | 2013 |
| The acute metabolic effects of tumor necrosis factor administration in humans RS Warren, HF Starnes, JL Gabrilove, HF Oettgen, MF Brennan Archives of Surgery 122 (12), 1396-1400, 1987 | 322 | 1987 |
| Intravascular adenoviral agents in cancer patients: lessons from clinical trials T Reid, R Warren, D Kirn Cancer gene therapy 9 (12), 979-986, 2002 | 321 | 2002 |
| Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. PB Chapman, TJ Lester, ES Casper, JL Gabrilove, GY Wong, SJ Kempin, ... Journal of Clinical Oncology 5 (12), 1942-1951, 1987 | 315 | 1987 |
